supp.fit

Pine Bark Extract: study protocols

39 study groups say how much Pine Bark Extract participants took a day. These are the doses the studies gave. They are not a recommendation.

Pine Bark Extract: what the research found →

Dose per serving from products

321 products in our catalogue print how much Pine Bark Extract a serving holds.

Most common: 25 mg to 50 mg, 22% of 321 products.

Dose per servingProducts
5 mg or less
10
5 mg to 10 mg
26
10 mg to 25 mg
55
25 mg to 50 mg
71
50 mg to 100 mg
64
100 mg to 250 mg
69
250 mg to 500 mg
25
over 500 mg
1

Dose per serving from research

38 study groups in 32 studies say how much Pine Bark Extract participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 100 mg to 250 mg, 45% of 38 study groups.

Daily doseStudy groups
25 mg or less
2
25 mg to 50 mg
6
50 mg to 100 mg
8
100 mg to 250 mg
17
250 mg to 500 mg
4
over 500 mg
1

Commonly used together

1 of 39 study groups took Pine Bark Extract with something else, but nothing that 3 or more different studies gave.

39 study groups

Study
Effect of Pycnogenol on the Healing of Venous Ulcers
2017 · Group 1 · Adults with venous ulcers
150 mg90 days15
Treatment of osteoarthritis with Pycnogenol. The SVOS (San Valentino Osteo-arthrosis Study). Evaluation of signs, symptoms, physical performance and vascular aspects
2008 · Treatment group · Patients with osteoarthritis; age and sex range not reported
100 mg90 days77
Impact of a Dietary Supplementation with French Maritime Pine Bark Extract Pycnogenol(®) on Salivary and Serum Inflammatory Biomarkers During Non-Surgical Periodontal Therapy-A Randomized Placebo-Controlled Double-Blind Trial
2025 · Pycnogenol® group · Adults aged 35–85 with gingival inflammation (at least 10% bleeding on probing), BMI 20–30 kg/m², and at least 10 natural teeth
200 mg90 days46
Treatment of vascular retinopathies with Pycnogenol
2001 · Pycnogenol · Patients with diabetes, atherosclerosis, or other vascular diseases involving the retina
150 mg60 days30
Oral administration of French maritime pine bark extract (Flavangenol(®)) improves clinical symptoms in photoaged facial skin
2012 · high-dose PBE trial · Healthy women aged 31–59 with age spots and mild-to-moderate facial photodamage
100 mg12 weeks24
Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study
2012 · Pycnogenol treatment · Adults with coronary artery disease (CAD); age and sex not specified
200 mg8 weeks23
A Placebo-Controlled, Pseudo-Randomized, Crossover Trial of Botanical Agents for Gulf War Illness: Curcumin (Curcuma longa), Boswellia (Boswellia serrata), and French Maritime Pine Bark (Pinus pinaster)
2021 · lower-dose maritime pine · Men aged 47–65 with Gulf War Illness, excluding those with prediabetes, diabetes evidence, or diabetic medication use
200 mg30 days10
A Placebo-Controlled, Pseudo-Randomized, Crossover Trial of Botanical Agents for Gulf War Illness: Curcumin (Curcuma longa), Boswellia (Boswellia serrata), and French Maritime Pine Bark (Pinus pinaster)
2021 · higher-dose maritime pine · Men aged 47–65 with Gulf War Illness, excluding those with prediabetes, diabetes evidence, or diabetic medication use
400 mg30 days10
Pycnogenol, French maritime pine bark extract, augments endothelium-dependent vasodilation in humans
2007 · Pycnogenol · Healthy young men
180 mg2 weeks8
Pycnogenol in chronic venous insufficiency
2000 · Pycnogenol · Patients with chronic venous insufficiency and leg varices
300 mg60 days—
Comparative study of Venostasin and Pycnogenol in chronic venous insufficiency
2002 · Pycnogenol · Patients with diagnosed chronic venous insufficiency; age and sex not reported
360 mg4 weeks—
A randomised, double-blind, placebo-controlled trial on the effect of Pycnogenol on the climacteric syndrome in peri-menopausal women
2007 · Pycnogenol · Peri-menopausal women with climacteric symptoms
200 mg——
Effect of pine bark extract (Pycnogenol) on symptoms of knee osteoarthritis
2008 · Pycnogenol · Patients with stage I or II knee osteoarthritis
150 mg90 days—
Improvement of signs and symptoms of chronic venous insufficiency and microangiopathy with Pycnogenol: a prospective, controlled study
2010 · group treated with Pycnogenol only · Adults with symptomatic chronic venous insufficiency and edema
150 mg8 weeks—
Improvement of signs and symptoms of chronic venous insufficiency and microangiopathy with Pycnogenol: a prospective, controlled study
2010 · group treated with both Pycnogenol and elastic stockings · Adults with symptomatic chronic venous insufficiency and edema
150 mg8 weeks—
French maritime pine bark extract (pycnogenol) in association with triple combination cream for the treatment of facial melasma in women: a double-blind, randomized, placebo-controlled trial
2021 · Pycnogenol (PYC) · Women with facial melasma; age range not reported
150 mg60 days—
Effect of low-dose French maritime pine bark extract on climacteric syndrome in 170 perimenopausal women: a randomized, double-blind, placebo-controlled trial
2013 · Pycnogenol group · Perimenopausal women
60 mg90 days85
Pycnogenol supplementation as an adjunct treatment for antidepressant-induced sexual dysfunction
2019 · ESC + PYC group · Outpatients of both genders with depression receiving escitalopram and experiencing antidepressant-induced sexual dysfunction
50 mg120 days37
French maritime pine bark extract significantly lowers the requirement for analgesic medication in dysmenorrhea: a multicenter, randomized, double-blind, placebo-controlled study
2008 · Pycnogenol group · Women aged 18–48 years with low menstrual pain or dysmenorrhea
60 mg——
Reduction of cardiovascular risk factors in subjects with type 2 diabetes by Pycnogenol supplementation
2008 · Pycnogenol · Adults with type 2 diabetes and mild to moderate hypertension, receiving ACE inhibitors
125 mg12 weeks—
Effect of French maritime pine bark extract supplementation on metabolic status and serum vascular cell adhesion molecule-1 levels in patients with type 2 diabetes and microalbuminuria
2021 · PBE group · Patients aged 30–65 years with type 2 diabetes and microalbuminuria
100 mg8 weeks—
Oral administration of French maritime pine bark extract (Flavangenol(®)) improves clinical symptoms in photoaged facial skin
2012 · Group 2, low-dose PBE treatment phase · Healthy women with age spots and mild-to-moderate facial photodamage
40 mg12 weeks39
Oral administration of French maritime pine bark extract (Flavangenol(®)) improves clinical symptoms in photoaged facial skin
2012 · Group 1, low-dose PBE · Healthy women with age spots and mild-to-moderate facial photodamage
40 mg24 weeks38
Oral administration of French maritime pine bark extract (Flavangenol(®)) improves clinical symptoms in photoaged facial skin
2012 · Part 2 long-term PBE participants · Healthy women with age spots and mild-to-moderate facial photodamage who completed the low-dose study
40 mg1 year24
The effect of antioxidant supplementation on fatigue during exercise: potential role for NAD+(H)
2010 · SUPPL (Lactaway) · Healthy trained and untrained males; trained cyclists or triathletes and untrained men from the general population, mean ages 30 and 29 years, respectively
360 mcg1 day13
Treatment of ADHD with French maritime pine bark extract, Pycnogenol
2006 · Pycnogenol · Children with ADHD; ages and sex not stated
1 mg/kg4 weeks—
Effect of a polyphenol-rich dietary supplement containing Pinus massoniana bark extract on blood pressure in healthy adults: A parallel, randomized placebo-controlled trial
2022 · PMBE group · Healthy Australian adults aged 55–75 years
1.32 g12 weeks—
Oral Pycnogenol® Intake Benefits the Skin in Urban Chinese Outdoor Workers: A Randomized, Placebo-Controlled, Double-Blind, and Crossover Intervention Study
2021 · Pycnogenol® intake · Han Chinese outdoor workers in Beijing; age and sex not specified
100 mg12 weeks76
Oligopin® Supplementation Mitigates Oxidative Stress in Postmenopausal Women with Osteopenia: A Randomized, Double-blind, Placebo-Controlled Trial
2021 · Oligopin® · Postmenopausal women with osteopenia
150 mg12 weeks22
Effects of French maritime pine bark extract (Oligopin®) supplementation on bone remodeling markers in postmenopausal osteopenic women: A randomized clinical trial
2019 · FMPBE · Postmenopausal women with osteopenia
250 mg12 weeks21
Distribution of Constituents and Metabolites of Maritime Pine Bark Extract (Pycnogenol(®)) into Serum, Blood Cells, and Synovial Fluid of Patients with Severe Osteoarthritis: A Randomized Controlled Trial
2017 · Pycnogenol group · Patients with severe osteoarthritis scheduled for elective knee replacement; mean age 64.3 years, both sexes
100 mg3 weeks16
Cellular pharmacodynamic effects of Pycnogenol® in patients with severe osteoarthritis: a randomized controlled pilot study
2017 · Pycnogenol® group · Adults with severe knee osteoarthritis (Kellgren-Lawrence grade III–IV) scheduled for elective arthroplasty; mean age about 64 years, women and men
200 mg3 weeks16
Pycnogenol, French maritime pine bark extract, improves endothelial function of hypertensive patients
2004 · Pycnogenol group · Patients with hypertension
100 mg12 weeks—
Comparison of Pycnogenol and Daflon in treating chronic venous insufficiency: a prospective, controlled study
2006 · Pycnogenol 150 mg daily · Patients with severe chronic venous insufficiency, venous hypertension, ankle swelling, and previous venous ulcerations; age and sex not reported
150 mg8 weeks—
Comparison of Pycnogenol and Daflon in treating chronic venous insufficiency: a prospective, controlled study
2006 · Pycnogenol 300 mg daily · Patients with severe chronic venous insufficiency, venous hypertension, ankle swelling, and previous venous ulcerations; age and sex not reported
300 mg8 weeks—
The effect of French maritime pine bark extract supplementation on inflammation, nutritional and clinical status in critically ill patients with traumatic brain injury: A randomized controlled trial
2021 · intervention group · Critically ill patients with traumatic brain injury admitted to intensive care units; age and sex not stated
150 mg10 days—
A controlled study shows daily intake of 50 mg of French Pine Bark Extract (Pycnogenol®) lowers plasma reactive oxygen metabolites in healthy smokers
2013 · Pycnogenol group · Healthy cigarette smokers
50 mg8 weeks78
Effects of French Pine Bark Extract Chewing Gum on Oral Malodor and Salivary Bacteria
2018 · PYC gum · Healthy adults aged 40.1 ± 12.3 years with threshold breath sulfur compounds
15 mg4 weeks—
Circulating levels of reactive oxygen species in patients with nonproliferative diabetic retinopathy and the influence of antioxidant supplementation: 6-month follow-up
2015 · Group A (antioxidant dietary supplementation) · Adults aged 40–79 with type 2 diabetes and mild or moderate nonproliferative diabetic retinopathy
50 mg26 weeks34